Anzeige
Mehr »
Login
Samstag, 11.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Innocan Pharma News: Unfassbare Studie - LPT-Therapie bewahrt Patient vor dem Tod!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DZZ2 | ISIN: US2666055007 | Ticker-Symbol: DC8A
Tradegate
08.05.24
11:43 Uhr
1,250 Euro
+0,260
+26,26 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
DURECT CORPORATION Chart 1 Jahr
5-Tage-Chart
DURECT CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
0,9601,00010.05.
0,9701,00010.05.

Aktuelle News zur DURECT Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
30.04.DURECT CORP - 8-K, Current Report6
01.04.DURECT Corporation (DRRX) Q4 2023 Earnings Call Transcript7
28.03.DURECT CORP - 10-K, Annual Report1
27.03.DURECT Corp reports results for the quarter ended in December - Earnings Summary5
27.03.DURECT Corp. Q4 Loss decreases, beats estimates2
27.03.Durect: Q4 Earnings Insights1
27.03.DURECT GAAP EPS of -$0.10 beats by $0.26, revenue of $2.67M misses by $0.03M2
27.03.DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update42- Ongoing Communication with FDA to Align on Next Steps for Larsucosterol in Alcohol-Associated Hepatitis - Webcast of Earnings Call Today, March 27th at 4:30 p.m. ET CUPERTINO, Calif., March 27...
► Artikel lesen
26.03.Durect's Earnings: A Preview2
22.03.DURECT CORP - 8-K, Current Report2
04.03.DURECT CORP - 8-K, Current Report3
04.03.DURECT and Charles River enter agreement for alzet in U.S., Canada6
04.03.DURECT Inks Co-marketing And Collaboration Deal With Charles River For ALZET Product Line3
04.03.DURECT Corporation: DURECT and Charles River Laboratories Enter into Co-Marketing and Collaboration Agreement for ALZET Product Line in U.S. and Canada118Partnership agreement will be the first-ever co-marketing and sales collaboration for the ALZET Osmotic Pumps Portfolio and Associated Product Line in the U.S. and Canada Both companies will jointly...
► Artikel lesen
22.12.23DURECT CORP - 8-K, Current Report4
14.11.23Earnings call: DURECT reports Q3 2023 financial results, positive clinical trial results12
13.11.23DURECT Corp reports results for the quarter ended in September - Earnings Summary3
13.11.23Recap: Durect Q3 Earnings2
13.11.23DURECT Corporation Reports Third Quarter 2023 Financial Results and Business Update161- Webcast of Earnings Call Today, November 13th at 4:30 p.m. ET - Topline data from AHFIRM trial showed compelling efficacy signal in favor of larsucosterol in the key secondary endpoint of mortality...
► Artikel lesen
09.08.23DURECT Corporation Reports Second Quarter 2023 Financial Results and Business Update143- Webcast of Earnings Call Today, August 9th at 4:30 p.m. ET - Topline data from AHFIRM trial expected in Q4 2023 CUPERTINO, Calif., Aug. 9, 2023 /PRNewswire/ -- DURECT Corporation (Nasdaq:...
► Artikel lesen
20 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1